+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Active Pharmaceutical Ingredient Market Research Report by Manufacturer, by Type, by Synthesis, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4989866
  • Report
  • July 2021
  • Region: Global
  • 187 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Active Pharmaceutical Ingredient Market will Grow to USD 275.23 Billion by 2026, at a CAGR of 6.49%

FEATURED COMPANIES

  • Abbvie Inc.
  • Astrazeneca
  • BASF SE
  • Bristol-Myers Squibb
  • ELI Lilly and Company
  • Glaxosmithkline PLC
The Global Active Pharmaceutical Ingredient Market size was estimated at USD 188.62 Billion in 2020 and expected to reach USD 200.25 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 6.49% to reach USD 275.23 Billion by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Active Pharmaceutical Ingredient to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Manufacturer, the Active Pharmaceutical Ingredient Market was studied across Captive API Manufacturers and Merchant API Manufacturers.
  • Based on Therapeutic Application, the Active Pharmaceutical Ingredient Market was studied across Cardiovascular Diseases, Communicable Diseases, Diabetes, Oncology, Pain Management, and Respiratory Diseases.
  • Based on Type, the Active Pharmaceutical Ingredient Market was studied across Generic Active Pharmaceutical Ingredients and Innovative Active Pharmaceutical Ingredients.
  • Based on Synthesis, the Active Pharmaceutical Ingredient Market was studied across Biotech Active Pharmaceutical Ingredients and Synthetic Active Pharmaceutical Ingredients.
  • Based on Region, the Active Pharmaceutical Ingredient Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Active Pharmaceutical Ingredient Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Active Pharmaceutical Ingredient Market, including Abbvie Inc., API Pharma Tech, Astrazeneca, Aurobindo Pharma, BASF SE, BDR Pharmaceuticals Internationals Pvt. Ltd., Boehringer Ingelheim, Bristol-Myers Squibb, Cipla, Inc., Dr. Reddy's Laboratories Ltd, ELI Lilly and Company, F. Hoffmann-La Roche, Glaxosmithkline PLC, Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer, Inc., Sanofi, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Active Pharmaceutical Ingredient Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Active Pharmaceutical Ingredient Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Active Pharmaceutical Ingredient Market?
4. What is the competitive strategic window for opportunities in the Global Active Pharmaceutical Ingredient Market?
5. What are the technology trends and regulatory frameworks in the Global Active Pharmaceutical Ingredient Market?
6. What is the market share of the leading vendors in the Global Active Pharmaceutical Ingredient Market?
7. What modes and strategic moves are considered suitable for entering the Global Active Pharmaceutical Ingredient Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbvie Inc.
  • Astrazeneca
  • BASF SE
  • Bristol-Myers Squibb
  • ELI Lilly and Company
  • Glaxosmithkline PLC
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Manufacturer Outlook
3.4. Therapeutic Application Outlook
3.5. Type Outlook
3.6. Synthesis Outlook
3.7. Region Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of chronic diseases
5.1.1.2. Growing importance of generics coupled with uptakes of biopharmaceuticals
5.1.1.3. Technological advancements in active pharmaceutical ingredients
5.1.1.4. Adoption of AI-based tools and organ-on-chip models in drug discovery & development
5.1.1.5. Rising focus on precision medicine and growing investment
5.1.2. Restraints
5.1.2.1. Unsupportive price control policies for drug across various countries
5.1.2.2. Increasing availability of counterfeit drugs
5.1.3. Opportunities
5.1.3.1. Emergence of biosimilars
5.1.3.2. Highly effective active pharmaceutical ingredients
5.1.4. Challenges
5.1.4.1. High cost associated with the manufacturing process
5.1.4.2. Concern associated with the product differentiation
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Active Pharmaceutical Ingredient Market, by Manufacturer
6.1. Introduction
6.2. Captive API Manufacturers
6.3. Merchant API Manufacturers

7. Active Pharmaceutical Ingredient Market, by Therapeutic Application
7.1. Introduction
7.2. Cardiovascular Diseases
7.3. Communicable Diseases
7.4. Diabetes
7.5. Oncology
7.6. Pain Management
7.7. Respiratory Diseases

8. Active Pharmaceutical Ingredient Market, by Type
8.1. Introduction
8.2. Generic Active Pharmaceutical Ingredients
8.3. Innovative Active Pharmaceutical Ingredients

9. Active Pharmaceutical Ingredient Market, by Synthesis
9.1. Introduction
9.2. Biotech Active Pharmaceutical Ingredients
9.3. Synthetic Active Pharmaceutical Ingredients

10. Americas Active Pharmaceutical Ingredient Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Active Pharmaceutical Ingredient Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Thailand

12. Europe, Middle East & Africa Active Pharmaceutical Ingredient Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Abbvie Inc.
14.2. API Pharma Tech
14.3. Astrazeneca
14.4. Aurobindo Pharma
14.5. BASF SE
14.6. BDR Pharmaceuticals Internationals Pvt. Ltd.
14.7. Boehringer Ingelheim
14.8. Bristol-Myers Squibb
14.9. Cipla, Inc.
14.10. Dr. Reddy's Laboratories Ltd
14.11. ELI Lilly and Company
14.12. F. Hoffmann-La Roche
14.13. Glaxosmithkline PLC
14.14. Merck & Co., Inc.
14.15. Mylan N.V.
14.16. Novartis AG
14.17. Pfizer, Inc.
14.18. Sanofi
14.19. Sun Pharmaceutical Industries Ltd
14.20. Teva Pharmaceutical Industries Ltd

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2020 (USD BILLION)
FIGURE 3. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2020 (USD BILLION)
FIGURE 4. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2020 (USD BILLION)
FIGURE 5. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2020 (USD BILLION)
FIGURE 6. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY REGION, 2020 (USD BILLION)
FIGURE 7. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 8. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: MARKET DYNAMICS
FIGURE 9. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 10. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2020 VS 2026 (%)
FIGURE 11. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2020 VS 2026 (USD BILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2026
FIGURE 13. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY CAPTIVE API MANUFACTURERS, 2018-2026 (USD BILLION)
FIGURE 14. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY CAPTIVE API MANUFACTURERS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 15. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MERCHANT API MANUFACTURERS, 2018-2026 (USD BILLION)
FIGURE 16. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MERCHANT API MANUFACTURERS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 17. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2020 VS 2026 (%)
FIGURE 18. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2020 VS 2026 (USD BILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2026
FIGURE 20. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2026 (USD BILLION)
FIGURE 21. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 22. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY COMMUNICABLE DISEASES, 2018-2026 (USD BILLION)
FIGURE 23. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY COMMUNICABLE DISEASES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 24. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY DIABETES, 2018-2026 (USD BILLION)
FIGURE 25. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY DIABETES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 26. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY ONCOLOGY, 2018-2026 (USD BILLION)
FIGURE 27. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 28. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2026 (USD BILLION)
FIGURE 29. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 30. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2026 (USD BILLION)
FIGURE 31. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 32. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 33. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2020 VS 2026 (USD BILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2026
FIGURE 35. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS, 2018-2026 (USD BILLION)
FIGURE 36. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 37. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS, 2018-2026 (USD BILLION)
FIGURE 38. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 39. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2020 VS 2026 (%)
FIGURE 40. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2020 VS 2026 (USD BILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2026
FIGURE 42. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS, 2018-2026 (USD BILLION)
FIGURE 43. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 44. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS, 2018-2026 (USD BILLION)
FIGURE 45. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 46. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 47. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 48. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 49. CANADA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 50. MEXICO ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 51. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 52. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 53. AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 54. CHINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 55. INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 56. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 57. JAPAN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 58. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 59. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 60. SINGAPORE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 61. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 62. THAILAND ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 64. FRANCE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 65. GERMANY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 66. ITALY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 67. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 68. QATAR ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 69. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 70. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 71. SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 72. SPAIN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 73. UNITED ARAB EMIRATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 74. UNITED KINGDOM ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 75. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: FPNV POSITIONING MATRIX
FIGURE 76. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 77. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 5. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MANUFACTURER, 2018-2026 (KILOTON)
TABLE 7. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY CAPTIVE API MANUFACTURERS, BY REGION, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY CAPTIVE API MANUFACTURERS, BY REGION, 2018-2026 (KILOTON)
TABLE 9. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MERCHANT API MANUFACTURERS, BY REGION, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY MERCHANT API MANUFACTURERS, BY REGION, 2018-2026 (KILOTON)
TABLE 11. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY THERAPEUTIC APPLICATION, 2018-2026 (KILOTON)
TABLE 13. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2026 (KILOTON)
TABLE 15. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY COMMUNICABLE DISEASES, BY REGION, 2018-2026 (USD BILLION)
TABLE 16. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY COMMUNICABLE DISEASES, BY REGION, 2018-2026 (KILOTON)
TABLE 17. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY DIABETES, BY REGION, 2018-2026 (USD BILLION)
TABLE 18. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY DIABETES, BY REGION, 2018-2026 (KILOTON)
TABLE 19. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2026 (USD BILLION)
TABLE 20. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY ONCOLOGY, BY REGION, 2018-2026 (KILOTON)
TABLE 21. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2026 (USD BILLION)
TABLE 22. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY PAIN MANAGEMENT, BY REGION, 2018-2026 (KILOTON)
TABLE 23. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2026 (USD BILLION)
TABLE 24. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY RESPIRATORY DISEASES, BY REGION, 2018-2026 (KILOTON)
TABLE 25. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018-2026 (USD BILLION)
TABLE 26. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY TYPE, 2018-2026 (KILOTON)
TABLE 27. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2018-2026 (USD BILLION)
TABLE 28. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2018-2026 (KILOTON)
TABLE 29. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2018-2026 (USD BILLION)
TABLE 30. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2018-2026 (KILOTON)
TABLE 31. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018-2026 (USD BILLION)
TABLE 32. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHESIS, 2018-2026 (KILOTON)
TABLE 33. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2018-2026 (USD BILLION)
TABLE 34. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2018-2026 (KILOTON)
TABLE 35. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2018-2026 (USD BILLION)
TABLE 36. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, BY SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2018-2026 (KILOTON)
TABLE 37. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 39. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 41. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 43. CANADA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. CANADA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 45. MEXICO ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 46. MEXICO ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 47. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 48. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 49. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 50. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 51. AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 52. AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 53. CHINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 54. CHINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 55. INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 56. INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 57. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 58. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 59. JAPAN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 60. JAPAN ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 61. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 62. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 63. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 64. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 65. SINGAPORE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 66. SINGAPORE ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 67. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 68. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 69. THAILAND ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 70. THAILAND ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 73. FRANCE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 74. FRANCE ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 75. GERMANY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 76. GERMANY ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 77. ITALY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 78. ITALY ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 79. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 80. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 81. QATAR ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 82. QATAR ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 83. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 84. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 85. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 86. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 87. SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 88. SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 89. SPAIN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 90. SPAIN ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 91. UNITED ARAB EMIRATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 92. UNITED ARAB EMIRATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 93. UNITED KINGDOM ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 94. UNITED KINGDOM ACTIVE PHARMACEUTICAL INGREDIENT MARKET VOLUME, 2018-2026 (KILOTON)
TABLE 95. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: SCORES
TABLE 96. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: BUSINESS STRATEGY
TABLE 97. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: PRODUCT SATISFACTION
TABLE 98. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: RANKING
TABLE 99. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 100. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: MERGER & ACQUISITION
TABLE 101. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 102. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 103. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: INVESTMENT & FUNDING
TABLE 104. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 105. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbvie Inc.
  • API Pharma Tech
  • Astrazeneca
  • Aurobindo Pharma
  • BASF SE
  • BDR Pharmaceuticals Internationals Pvt. Ltd.
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Cipla, Inc.
  • Dr. Reddy's Laboratories Ltd
  • ELI Lilly and Company
  • F. Hoffmann-La Roche
  • Glaxosmithkline PLC
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll